[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2662995A - Lysozyme-degradable biomaterials - Google Patents

Lysozyme-degradable biomaterials

Info

Publication number
AU2662995A
AU2662995A AU26629/95A AU2662995A AU2662995A AU 2662995 A AU2662995 A AU 2662995A AU 26629/95 A AU26629/95 A AU 26629/95A AU 2662995 A AU2662995 A AU 2662995A AU 2662995 A AU2662995 A AU 2662995A
Authority
AU
Australia
Prior art keywords
chitin
bioactive agent
composition according
lysozyme
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26629/95A
Other languages
English (en)
Inventor
George L Brode
Jeff J Prior
Ronald K Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitaphore Corp
Original Assignee
Vitaphore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaphore Corp filed Critical Vitaphore Corp
Publication of AU2662995A publication Critical patent/AU2662995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AU26629/95A 1994-06-02 1995-06-02 Lysozyme-degradable biomaterials Abandoned AU2662995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US252721 1981-04-10
US25272194A 1994-06-02 1994-06-02
PCT/US1995/007153 WO1995033773A1 (en) 1994-06-02 1995-06-02 Lysozyme-degradable biomaterials

Publications (1)

Publication Number Publication Date
AU2662995A true AU2662995A (en) 1996-01-04

Family

ID=22957249

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26629/95A Abandoned AU2662995A (en) 1994-06-02 1995-06-02 Lysozyme-degradable biomaterials

Country Status (5)

Country Link
EP (1) EP0763063A4 (de)
JP (1) JPH10504277A (de)
AU (1) AU2662995A (de)
CA (1) CA2191753A1 (de)
WO (1) WO1995033773A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1020716C2 (nl) * 2002-05-30 2003-12-02 Tno Antimicrobiele verpakkingen.
US8771649B2 (en) 2003-05-30 2014-07-08 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Inducible release vehicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993071A (en) * 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3993057A (en) * 1972-12-27 1976-11-23 Alza Corporation Intrauterine device that bioerodes in response to the environment of the uterus and method of using
US5290752A (en) * 1984-03-16 1994-03-01 Unitika Ltd. Method for preparation of a shaped chitin body containing a physiologically active substance
ATE144781T1 (de) * 1986-06-06 1996-11-15 Union Carbide Corp Saure dekristallisierung von hochkristallin chitosan oder teilentacetylierten chitin
US4929722A (en) * 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
EP0426368B1 (de) * 1989-10-31 1995-01-04 Howmedica Inc. Chitinderivate enthaltende Zusammensetzungen zur Verhütung der Adhäsion
US5219749A (en) * 1991-10-09 1993-06-15 Institute For Molecular Biology & Biotechnology/Forth Process for isolating and preparing purified chitin deacetylase
JP2998422B2 (ja) * 1992-04-02 2000-01-11 株式会社デンソー 熱交換器

Also Published As

Publication number Publication date
WO1995033773A1 (en) 1995-12-14
EP0763063A4 (de) 1998-09-16
JPH10504277A (ja) 1998-04-28
EP0763063A1 (de) 1997-03-19
CA2191753A1 (en) 1995-12-14

Similar Documents

Publication Publication Date Title
EP0537292B1 (de) Wasserunlösliche Hyaluronsäureabkömmlinge
AU622699B2 (en) Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
Banks et al. Chemical modification of alginate for controlled oral drug delivery
US5041292A (en) Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
JP3094074B2 (ja) 多糖ゲル組成物
EP3412313B1 (de) Temperaturempfindliche hydrogelzusammensetzung mit nukleinsäure und chitosan
EP0533809B1 (de) Polyurethan-biopolymer verbindung
US6030958A (en) Water insoluble derivatives of hyaluronic acid
Chak et al. A review on collagen based drug delivery systems
EP1595534A1 (de) Gelzusammensetzung enthaltend geladenepolymere
EP2100914B1 (de) Verfahren zur herstellung von modifiziertem biopolymer und verfahren zum vernetzen von biopolymeren
JPH0834747A (ja) コラーゲンベースの注入可能な薬剤送達製剤およびその使用
JP2008520783A (ja) ヒドロゲルマトリックスおよびマイクロキャリアを含む活性物質供給システム
JP2003508128A (ja) 生物活性物質及びその調製物を担持する新規多層型材料
WO2008103046A1 (en) A controlled release composition
US5788959A (en) Drug delivery device and method for employing the same
Graham et al. Polymeric inserts and implants for the controlled release of drugs
EP0136013B1 (de) Verfahren zur Herstellung eines biologisch abbaubaren Arzneimittelspenders und ein auf diese Weise hergestellter Arzneimittelspender
EP0548344B1 (de) Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
AU2662995A (en) Lysozyme-degradable biomaterials
Thakur et al. Gelatin based matrices for drug delivery applications
Lee et al. Preparation of collagen modified hyaluronan microparticles as antibiotics carrier
JP3898783B2 (ja) 生体内分解性ヒアルロン酸架橋ゲル組成物及び生体内分解性ヒアルロン酸架橋ゲル製剤
Pradeep et al. Pharmaceutical Hydrogels: A Comprehensive Review
LANKAPALLI et al. APPLICATIONS OF BIODEGRADABLE NATURAL POLYMERS AS DRUG DELIVERY SYSTEMS: A REVIEW